99
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluation of the Prognostic Role of Neutrophil-Lymphocyte Ratio, C-Reactive Protein-Albumin Ratio, and Platelet-Lymphocyte Ratio in Patients with the Co-Presentation of Coronary Artery Disease and COVID-19

, , , , , , , & ORCID Icon show all
Pages 885-897 | Received 03 Dec 2023, Accepted 27 Feb 2024, Published online: 07 Mar 2024

References

  • Tardif JC, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497–2505. doi:10.1056/NEJMoa1912388
  • Nidorf SM, Fiolet A, Mosterd A, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838–1847. doi:10.1056/NEJMoa2021372
  • Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131. doi:10.1056/NEJMoa1707914
  • Adamstein NH, MacFadyen JG, Rose LM, et al. The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. EUR HEART J. 2021;42(9):896–903. doi:10.1093/eurheartj/ehaa1034
  • Menon V, Greene T, Wang X, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005;68(2):766–772. doi:10.1111/j.1523-1755.2005.00455.x
  • Cheng L, Meng Z, Wang Q, et al. The usefulness of c-reactive protein to albumin ratio in the prediction of adverse cardiovascular events in coronary chronic total occlusion undergoing percutaneous coronary intervention. Front Cardiovasc Med. 2021;8:731261. doi:10.3389/fcvm.2021.731261
  • Li J, Zhu P, Li Y, et al. A novel inflammatory biomarker, high-sensitivity C-reactive protein-to-albumin ratio, is associated with 5-year outcomes in patients with type 2 diabetes who undergo percutaneous coronary intervention. Diabetol Metab Syndr. 2023;15(1):14. doi:10.1186/s13098-022-00977-9
  • Yang X, Yang X, Yang J, Wen X, Wu S, Cui L. High levels of high-sensitivity C reactive protein to albumin ratio can increase the risk of cardiovascular disease. J Epidemiol Community Health. 2023. doi:10.1136/jech-2023-220760
  • Tanriverdi Z, Gungoren F, Tascanov MB, Besli F, Altiparmak IH. Comparing the diagnostic value of the C-reactive protein to albumin ratio with other inflammatory markers in patients with stable angina pectoris. Angiology. 2020;71(4):360–365. doi:10.1177/0003319719897490
  • Xu X, Cai L, Chen T, et al. Predictive value of inflammation-based Glasgow prognostic score, platelet-lymphocyte ratio, and global registry of acute coronary events score for major cardiovascular and cerebrovascular events during hospitalization in patients with acute myocardial infarction. Aging. 2021;13(14):18274–18286. doi:10.18632/aging.203273
  • Zhu H, Li Z, Xu X, Fang X, Chen T, Huang J. Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study. Peerj. 2020;8:e9068.
  • Sia CH, Leow AS, Tan BY, et al. The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict left ventricular thrombus resolution in acute myocardial infarction without percutaneous coronary intervention. Thromb Res. 2020;194:16–20. doi:10.1016/j.thromres.2020.06.003
  • Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015;26(7):680–681. doi:10.3109/09537104.2014.979340
  • Condado JF, Junpaparp P, Binongo JN, et al. Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can risk stratify patients in transcatheter aortic-valve replacement (TAVR). Int J Cardiol. 2016;223:444–449. doi:10.1016/j.ijcard.2016.08.260
  • Seyit M, Avci E, Nar R, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021;40:110–114. doi:10.1016/j.ajem.2020.11.058
  • Karakoyun I, Colak A, Turken M, et al. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients. Int Immunopharmacol. 2021;91:107285. doi:10.1016/j.intimp.2020.107285
  • La Torre G, Marte M, Massetti AP, et al. The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control study. Eur Rev Med Pharmacol Sci. 2022;26(3):1056–1064. doi:10.26355/eurrev_202202_28017
  • Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237–269. doi:10.1093/eurheartj/ehy462
  • Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–477. doi:10.1093/eurheartj/ehz425
  • Zhao M, Qin E, Zhang D, et al. Expert consensus on clinical prevention and treatment of COVID-19. Med J Chin PLA. 2020;45(11):1109–1116.
  • Koppie TM, Serio AM, Vickers AJ, et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer-Am Cancer Soc. 2008;112(11):2384–2392.
  • Huang W, Berube J, McNamara M, et al. Lymphocyte subset counts in COVID-19 Patients: a meta-analysis. Cytometry A. 2020;97(8):772–776. doi:10.1002/cyto.a.24172
  • Guo L, Wei D, Zhang X, et al. Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score. Front Microbiol. 2019;10:2752. doi:10.3389/fmicb.2019.02752
  • Borges L, Pithon-Curi TC, Curi R, Hatanaka E. COVID-19 and neutrophils: the relationship between hyperinflammation and neutrophil extracellular traps. Mediators Inflamm. 2020;2020:8829674. doi:10.1155/2020/8829674
  • Ackermann M, Anders HJ, Bilyy R, et al. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ. 2021;28(11):3125–3139.
  • Reusch N, De Domenico E, Bonaguro L, et al. Neutrophils in COVID-19. Front Immunol. 2021;12:652470. doi:10.3389/fimmu.2021.652470
  • Neuen BL, Leather N, Greenwood AM, Gunnarsson R, Cho Y, Mantha ML. Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients. Ren Fail. 2016;38(1):70–76. doi:10.3109/0886022X.2015.1104990
  • Lano G, Sallée M, Pelletier M, et al. Neutrophil: lymphocyte ratio correlates with the uremic toxin indoxyl sulfate and predicts the risk of death in patients on hemodialysis. Nephrol Dial Transplant. 2022;37(12):2528–2537. doi:10.1093/ndt/gfab350
  • Lentner J, Adams T, Knutson V, et al. C-reactive protein levels associated with COVID-19 outcomes in the United States. J Osteopath Med. 2021;121(12):869–873. doi:10.1515/jom-2021-0103
  • Kaplangoray M, Toprak K, Aslan R, Deveci E, Gunes A, Ardahanli İ. High CRP-albumin ratio is associated high thrombus burden in patients with newly diagnosed STEMI. Medicine. 2023;102(41):e35363. doi:10.1097/MD.0000000000035363
  • Rathore SS, Oberoi S, Iqbal K, et al. Prognostic value of novel serum biomarkers, including C-reactive protein to albumin ratio and fibrinogen to albumin ratio, in COVID-19 disease: a meta-analysis. REV MED VIROL. 2022;32(6):e2390. doi:10.1002/rmv.2390